Keith L. Knutson

Department of Immunology

College of Medicine, Mayo Clinic

BIOGRAPHY

Keith L. Knutson has not added Biography.

If you are Keith L. Knutson and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Expert opinion on biological therapy Jan, 2002 | Pubmed ID: 11772340

Blood Apr, 2002 | Pubmed ID: 11929774

Clinical cancer research : an official journal of the American Association for Cancer Research May, 2002 | Pubmed ID: 12006513

Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun, 2002 | Pubmed ID: 12039923

Current opinion in investigational drugs (London, England : 2000) Jan, 2002 | Pubmed ID: 12054067

Human immunology Jul, 2002 | Pubmed ID: 12072190

Current opinion in molecular therapeutics Aug, 2002 | Pubmed ID: 12222879

Journal of clinical immunology Jan, 2003 | Pubmed ID: 12645861

Cancer chemotherapy and biological response modifiers , 2002 | Pubmed ID: 12703214

Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Nature medicine May, 2003 | Pubmed ID: 12704383

Immunobiology , 2003 | Pubmed ID: 12777059

Hematology/oncology clinics of North America Aug, 2003 | Pubmed ID: 12959191

Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity.

Molecular cancer therapeutics Oct, 2003 | Pubmed ID: 14578464

Clinical cancer research : an official journal of the American Association for Cancer Research Nov, 2003 | Pubmed ID: 14654536

Cancer research Feb, 2004 | Pubmed ID: 14871850

Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2004 | Pubmed ID: 15143085

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Nature medicine Sep, 2004 | Pubmed ID: 15322536

Cancer chemotherapy and biological response modifiers , 2003 | Pubmed ID: 15338750

Journal of clinical immunology Sep, 2004 | Pubmed ID: 15359116

Breast disease , 2004 | Pubmed ID: 15687702

Cancer immunology, immunotherapy : CII Jan, 2006 | Pubmed ID: 15891880

Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce "danger signals".

Breast cancer research and treatment Apr, 2006 | Pubmed ID: 16211331

Frontiers in bioscience : a journal and virtual library , 2006 | Pubmed ID: 16368569

Cancer research Jan, 2006 | Pubmed ID: 16424052

Molecular cancer therapeutics Jan, 2006 | Pubmed ID: 16432173

Journal of immunology (Baltimore, Md. : 1950) Jul, 2006 | Pubmed ID: 16785502

Future oncology (London, England) Jun, 2006 | Pubmed ID: 16787118

Cancer immunology, immunotherapy : CII Mar, 2007 | Pubmed ID: 16819631

Journal of immunology (Baltimore, Md. : 1950) Aug, 2006 | Pubmed ID: 16849459

Journal of clinical oncology : official journal of the American Society of Clinical Oncology Sep, 2006 | Pubmed ID: 16908932

Cancer research Oct, 2006 | Pubmed ID: 17018635

Cancer research Feb, 2007 | Pubmed ID: 17283170

HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses.

European journal of immunology Mar, 2007 | Pubmed ID: 17304628

Journal of immunology (Baltimore, Md. : 1950) Mar, 2007 | Pubmed ID: 17339455

Clinical cancer research : an official journal of the American Association for Cancer Research Mar, 2007 | Pubmed ID: 17363545

Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2007 | Pubmed ID: 17404089

The American journal of pathology Jun, 2007 | Pubmed ID: 17525251

Tumor immunoediting and immunosculpting pathways to cancer progression.

Seminars in cancer biology Aug, 2007 | Pubmed ID: 17662614

Clinical cancer research : an official journal of the American Association for Cancer Research Sep, 2007 | Pubmed ID: 17785568

Blood Feb, 2008 | Pubmed ID: 18029553

Gynecologic oncology Mar, 2008 | Pubmed ID: 18222534

Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors.

Cancer research Apr, 2008 | Pubmed ID: 18381452

Cancer research Jun, 2008 | Pubmed ID: 18559537

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.

Cancer research Apr, 2009 | Pubmed ID: 19276366

BMC cancer , 2009 | Pubmed ID: 19500386

Gastroenterology Oct, 2009 | Pubmed ID: 19577568

PloS one , 2009 | Pubmed ID: 19617914

Cancer immunology, immunotherapy : CII Jan, 2010 | Pubmed ID: 19621224

Therapeutic vaccines for malignant brain tumors.

Biologics : targets & therapy Dec, 2008 | Pubmed ID: 19707456

Expert review of neurotherapeutics Jul, 2003 | Pubmed ID: 19810935

GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.

Breast cancer research and treatment Aug, 2010 | Pubmed ID: 19898981

Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2010 | Pubmed ID: 20103660

Cancer immunology, immunotherapy : CII Jun, 2010 | Pubmed ID: 20140431

AIDS (London, England) Jun, 2010 | Pubmed ID: 20299954

Cancer research Apr, 2010 | Pubmed ID: 20395197

Journal of immunology (Baltimore, Md. : 1950) Jun, 2010 | Pubmed ID: 20483795

Journal of immunology (Baltimore, Md. : 1950) Jun, 2010 | Pubmed ID: 20495063

Journal of translational medicine , 2010 | Pubmed ID: 20529245

Cancer biomarkers : section A of Disease markers , 2010 | Pubmed ID: 20938089

Cancer causes & control : CCC May, 2011 | Pubmed ID: 21359843

Arthritis and rheumatism Jun, 2011 | Pubmed ID: 21384332

Immunotherapy Apr, 2011 | Pubmed ID: 21463194

Journal of immunology (Baltimore, Md. : 1950) Jun, 2011 | Pubmed ID: 21551365

Cancer research Jul, 2011 | Pubmed ID: 21555371

Journal of immunology (Baltimore, Md. : 1950) Jul, 2011 | Pubmed ID: 21613617

Clinical immunology (Orlando, Fla.) Oct, 2011 | Pubmed ID: 21703930

The American journal of pathology Jan, 2012 | Pubmed ID: 22067909

Mayo Clinic proceedings. Mayo Clinic Jan, 2012 | Pubmed ID: 22212964

Arthritis research & therapy , 2012 | Pubmed ID: 22293286

INSTITUTIONS

College of Medicine, Mayo Clinic

JOVE ARTICLES

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

Courtney L. Erskine¹,

Andrea M. Henle¹,

Keith L. Knutson¹

¹Department of Immunology, College of Medicine, Mayo Clinic

Immunology and Infection

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center
JoVE Sitemap

We use cookies to enhance your experience on our website.

By continuing to use our website or clicking “Continue”, you are agreeing to accept our cookies.

Learn More